Back to Search
Start Over
A Protected Class, An Unprotected Condition, and A Biomarker – A Method/Formula for Increased Diversity in Clinical Trials for the African American Subject with Benign Ethnic Neutropenia (BEN).
- Source :
-
American Journal of Law & Medicine . Mar2023, Vol. 49 Issue 1, p41-58. 18p. - Publication Year :
- 2023
-
Abstract
- Expanding on previous industry guidance relative to increased clinical trial diversity, while honing more exacting treatments and better ways to fight diseases that have often disproportionately impacted people of color, is a topic being discussed by multidisciplinary public health experts across the nation. This writing draws attention to the African American demographic, which is continually subject to health care disparities. Any glimpses of knowledge or medical discovery that could potentially help to redress harm or reinforce a weakened familial-cultural infrastructure should be emphasized for sanative restoration of the impacted communities. The focus of this writing is the African American cohort and its nexus to Benign Ethnic Neutropenia as the diverse target population of discussion, hoping to convey a harmonized approach in the examination of (1) the African American Benign Ethnic Neutropenia cohort within the context of basic scientific understanding, (2) the interplay of applicable governing regulatory protections, and (3) increased clinical trial participation to enlarge the pathway for increased diversity in clinical trials. [ABSTRACT FROM AUTHOR]
- Subjects :
- *NEUTROPENIA
*BIOMARKERS
*PUBLIC health
*PEOPLE of color
*CLINICAL drug trials
Subjects
Details
- Language :
- English
- ISSN :
- 00988588
- Volume :
- 49
- Issue :
- 1
- Database :
- Academic Search Index
- Journal :
- American Journal of Law & Medicine
- Publication Type :
- Academic Journal
- Accession number :
- 178761646
- Full Text :
- https://doi.org/10.1017/amj.2023.15